Association Between the Neutrophil-to-Lymphocyte Ratio and in-Stent Neoatherosclerosis and Plaque Vulnerability: An Optical Coherence Tomography Study

Ning Gu,Panke Chen,Xi Wang,Changyin Shen,Yi Deng,Jianling Chen,Yi Ma,Shuai Ma,Xingwei Hu,Ranzun Zhao,Bei Shi
DOI: https://doi.org/10.1097/fjc.0000000000001616
IF: 3.271
2024-11-08
Journal of Cardiovascular Pharmacology
Abstract:Percutaneous coronary intervention (PCI) has revolutionized the treatment of patients with coronary heart disease. 1 Compared with bare metal stents (BMS), drug-eluting stents (DES) substantially reduce angiographic and in-stent restenosis (ISR). 2,3 However, late and very late ISR still occur, which is attributed to in-stent neoatherosclerosis (ISNA), which proceeds more rapidly in DES compared with that of BMS. 4,5 Several studies have shown that local and systemic inflammatory responses play an important role in the development of ISNA and are predictors of ISR. 6,7 Therefore, a reliable and easy-to-measure biomarker of inflammation is needed to predict ISNA progression.
pharmacology & pharmacy,cardiac & cardiovascular systems
What problem does this paper attempt to address?